HDAC2 and Cognitive impairment: Unlike HDAC1, PET neuroimaging and other postmortem studies have confirmed that the expression of HDAC2 is decreased in the dorsolateral prefrontal cortex of SCZ patients, which may be associated with cognitive impairment (Schroeder et al., 2017; Gilbert et al., 2019).